These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up. Zaki AA, Farid SF. Cornea; 2009 Oct; 28(9):986-8. PubMed ID: 19724215 [Abstract] [Full Text] [Related]
6. Treatment of ocular surface squamous neoplasia with Mitomycin C. Gupta A, Muecke J. Br J Ophthalmol; 2010 May; 94(5):555-8. PubMed ID: 20447963 [Abstract] [Full Text] [Related]
7. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations. Demirci H, McCormick SA, Finger PT. Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099 [Abstract] [Full Text] [Related]
8. Topical cyclosporine-a combined with mitomycin C for conjunctival and corneal squamous cell carcinoma. Tunc M, Erbilen E. Am J Ophthalmol; 2006 Oct; 142(4):673-5. PubMed ID: 17011863 [Abstract] [Full Text] [Related]
13. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma. Prabhasawat P, Tarinvorakup P, Tesavibul N, Uiprasertkul M, Kosrirukvongs P, Booranapong W, Srivannaboon S. Cornea; 2005 May; 24(4):443-8. PubMed ID: 15829803 [Abstract] [Full Text] [Related]
14. Intraoperative mitomycin-C versus postoperative topical mitomycin-C drops for the treatment of pterygium. Helal M, Messiha N, Amayem A, el-Maghraby A, Elsherif Z, Dabees M. Ophthalmic Surg Lasers; 1996 Aug; 27(8):674-8. PubMed ID: 8858633 [Abstract] [Full Text] [Related]
15. Outcomes in 15 patients with conjunctival melanoma treated with adjuvant topical mitomycin C: complications and recurrences. Ditta LC, Shildkrot Y, Wilson MW. Ophthalmology; 2011 Sep; 118(9):1754-9. PubMed ID: 21652078 [Abstract] [Full Text] [Related]
16. Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia. Bahrami B, Greenwell T, Muecke JS. Clin Exp Ophthalmol; 2014 Sep; 42(4):317-22. PubMed ID: 23927413 [Abstract] [Full Text] [Related]
17. Chemoreduction with topical mitomycin C prior to resection of extensive squamous cell carcinoma of the conjunctiva. Shields CL, Demirci H, Marr BP, Masheyekhi A, Materin M, Shields JA. Arch Ophthalmol; 2005 Jan; 123(1):109-13. PubMed ID: 15642823 [No Abstract] [Full Text] [Related]
18. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Wilson MW, Hungerford JL, George SM, Madreperla SA. Am J Ophthalmol; 1997 Sep; 124(3):303-11. PubMed ID: 9439356 [Abstract] [Full Text] [Related]
19. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. Shields CL, Naseripour M, Shields JA. Am J Ophthalmol; 2002 May; 133(5):601-6. PubMed ID: 11992855 [Abstract] [Full Text] [Related]
20. [Topical treatment with mitomycin C in considerably raised conjunctival intraepithelial neoplasia]. Rodríguez-Pérez C, Del Campo Z, Wolley-Dod C, Gris O. Arch Soc Esp Oftalmol; 2002 Dec; 77(12):685-8. PubMed ID: 12471516 [Abstract] [Full Text] [Related] Page: [Next] [New Search]